EP1881843A4 - Kinase peptides and antibodies - Google Patents

Kinase peptides and antibodies

Info

Publication number
EP1881843A4
EP1881843A4 EP06759960A EP06759960A EP1881843A4 EP 1881843 A4 EP1881843 A4 EP 1881843A4 EP 06759960 A EP06759960 A EP 06759960A EP 06759960 A EP06759960 A EP 06759960A EP 1881843 A4 EP1881843 A4 EP 1881843A4
Authority
EP
European Patent Office
Prior art keywords
antibodies
kinase peptides
kinase
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06759960A
Other languages
German (de)
French (fr)
Other versions
EP1881843A2 (en
Inventor
Patrick J Muraca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuclea Biomarkers LLC
Original Assignee
Nuclea Biomarkers LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0601102.7A external-priority patent/GB0601102D0/en
Application filed by Nuclea Biomarkers LLC filed Critical Nuclea Biomarkers LLC
Publication of EP1881843A2 publication Critical patent/EP1881843A2/en
Publication of EP1881843A4 publication Critical patent/EP1881843A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
EP06759960A 2005-05-18 2006-05-17 Kinase peptides and antibodies Withdrawn EP1881843A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68211505P 2005-05-18 2005-05-18
GBGB0601102.7A GB0601102D0 (en) 2006-01-19 2006-01-19 Kinase Peptides And Antibodies
PCT/US2006/018974 WO2006124932A2 (en) 2005-05-18 2006-05-17 Kinase peptides and antibodies

Publications (2)

Publication Number Publication Date
EP1881843A2 EP1881843A2 (en) 2008-01-30
EP1881843A4 true EP1881843A4 (en) 2010-01-06

Family

ID=37432059

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06759960A Withdrawn EP1881843A4 (en) 2005-05-18 2006-05-17 Kinase peptides and antibodies

Country Status (2)

Country Link
EP (1) EP1881843A4 (en)
WO (1) WO2006124932A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015048367A1 (en) * 2013-09-26 2015-04-02 New York Genome Center, Inc. Fusion proteins and methods of use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003105773A2 (en) * 2002-06-01 2003-12-24 Oregon Health & Science University Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets:

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003105773A2 (en) * 2002-06-01 2003-12-24 Oregon Health & Science University Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets:

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HE Q ET AL: "THE CLINICAL SIGNIFICANCE OF THYMIDINE KINASE 1 MEASUREMENT IN SERUM OF BREAST CANCER PATIENTS USING ANTI-TK1 ANTIBODY", INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, WICHTIG EDITORE, MILAN, IT, vol. 15, no. 2, 1 January 2000 (2000-01-01), pages 139 - 146, XP008059258, ISSN: 0393-6155 *
HEINRICH MICHAEL C ET AL: "PDGFRA activating mutations in gastrointestinal stromal tumors.", SCIENCE (NEW YORK, N.Y.) 31 JAN 2003, vol. 299, no. 5607, 31 January 2003 (2003-01-31), pages 708 - 710, XP002557370, ISSN: 1095-9203 *
KIM W S ET AL: "Activation of signaling pathways by putative scavenger receptor class A (SR-A) ligands requires CD14 but not SR-A", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 310, no. 2, 17 October 2003 (2003-10-17), pages 542 - 549, XP004458977, ISSN: 0006-291X *
See also references of WO2006124932A2 *

Also Published As

Publication number Publication date
WO2006124932A2 (en) 2006-11-23
WO2006124932A3 (en) 2007-04-12
EP1881843A2 (en) 2008-01-30

Similar Documents

Publication Publication Date Title
IL272883A (en) Monoclonal antibodies and uses thereof
GB0601102D0 (en) Kinase Peptides And Antibodies
IL222922A (en) Anti-neuropilin-1 antibodies and uses thereof
IL235620A0 (en) Sp35 antibodies and uses thereof
IL187710A0 (en) Anti-trkb monoclonal antibodies and uses thereof
AP2008004471A0 (en) Anti-Alpha2 Intergin antibodies and their uses
IL184659A0 (en) Antibody variants and uses thereof
IL182554A0 (en) Anti-addl antibodies and uses thereof
IL184024A0 (en) Irta-5 antibodies and their uses
EP1915177A4 (en) Alpha-synuclein antibodies and methods related thereto
IL191820A0 (en) Anti-ox40l antibodies and methods using same
PT2343320T (en) Anti-gitr antibodies and uses thereof
IL178277A0 (en) Irta-5 antibodies and their uses
GB0517487D0 (en) Antibodies
IL185308A0 (en) Replikin peptides and uses thereof
ZA200703406B (en) Anti-ADDL antibodies and uses thereof
EP1896047A4 (en) Anti-gfralpha3 antibodies
GB0505489D0 (en) Antibodies
EP1881843A4 (en) Kinase peptides and antibodies
ZA200702281B (en) IRTA-4 antibodies and their uses
GB0512278D0 (en) Antibodies
GB0505054D0 (en) Antibodies
GB0511861D0 (en) Proteins
ZA200705716B (en) IRTA-2 antibodies and their uses
GB0507219D0 (en) Antibody and uses thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071116

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20091209

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 16/40 20060101AFI20091201BHEP

Ipc: A61K 39/00 20060101ALI20091201BHEP

Ipc: G01N 33/574 20060101ALI20091201BHEP

17Q First examination report despatched

Effective date: 20100406

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110923